A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer
Clinical trial NCT03522649 · UNKNOWN
Trial details
- NCT number
- NCT03522649
- Sponsor
- 1Globe Health Institute LLC
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2021-11-01
- Enrollment
- 668
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.